C. Gibson

发表

Ticagrelor With Aspirin or Alone After Complex PCI: The TWILIGHT-COMPLEX Analysis.

Samin K. Sharma, S. Pocock, G. Dangas, 2020, Journal of the American College of Cardiology.

Early glycoprotein IIb–IIIa inhibitors in primary angioplasty (EGYPT) cooperation: an individual patient data meta-analysis

G. Biondi-Zoccai, S. Murphy, D. Dudek, 2008, Heart.

Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry).

S. Pocock, T. Henry, G. Dangas, 2017, The American journal of cardiology.

Mechanical debulking versus balloon angioplasty for the treatment of diffuse in-stent restenosis.

H. Dauerman, D. Baim, D. Cohen, 1998, The American journal of cardiology.

Feasibility and Safety of Low-Dose Intra-Coronary Tenecteplase During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (ICE T-TIMI 49).

C. Gibson, G. Stouffer, K. Bainey, 2019, The American journal of cardiology.

Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.

R. Mehran, M. Fahy, H. Parise, 2013, American heart journal.

Impact of distal embolization on myocardial perfusion and survival among patients undergoing primary angioplasty with glycoprotein IIb–IIIa inhibitors: insights from the EGYPT cooperation

D. Dudek, M. Noc, K. Huber, 2010, Journal of Thrombosis and Thrombolysis.

Six-month angiographic and clinical follow-up of patients prospectively randomized to receive either tirofiban or placebo during angioplasty in the RESTORE trial. Randomized Efficacy Study of Tirofiban for Outcomes and Restenosis.

L. Deckelbaum, S. King, D. Cohen, 1998, Journal of the American College of Cardiology.

Ticagrelor With or Without Aspirin Following Percutaneous Coronary Intervention in High-Risk Patients With Concomitant Peripheral Artery Disease: a subgroup analysis of the TWILIGHT randomized clinical trial.

G. Dangas, U. Baber, B. Vogel, 2024, American heart journal.

Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)

S. Pocock, T. Henry, M. Krucoff, 2018, Circulation. Cardiovascular interventions.

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.

G. Dangas, D. Angiolillo, D. Heg, 2024, JAMA cardiology.

Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: results of a multicenter case-control study with 145 thrombosis events.

T. Ryan, H. Dauerman, A. Kirtane, 2008, American heart journal.

Patterns and associations between DAPT cessation and 2-year clinical outcomes in left main/proximal LAD versus other PCI: Results from the Patterns of Non-Adherence to Dual Antiplatelet Therapy in Stented Patients (PARIS) registry.

S. Pocock, T. Henry, G. Dangas, 2017, International journal of cardiology.

Clinically Driven Revascularization in High-Risk Patients Treated With Ticagrelor Monotherapy After PCI: Insights from the Randomized TWILIGHT Trial.

Samin K. Sharma, G. Dangas, S. Mehta, 2023, The American journal of cardiology.